Speech read on your trial’s own scale between visits, and a check of every recorded rating interview
Participants record a few minutes of speech at home on their own phone, and each reading is joined to the visit score. Trial QC returns flags per rater from the rating interviews that your sites or central rating vendor record.
Talk to our team
Built for regulated clinical trials
Speech readings between visits
Each reading sits on the scale your protocol already carries, joined to the visit score and pre‑specified in your SAP as an exploratory endpoint.
See speech biomarkersEvery recorded interview checked
At every site, screening interviews are read as their audio and scores arrive, so a score can be queried before randomization; baseline interviews are read before the next data transfer. Flags per rater go to your blinded study team or central rating vendor; Cephalgo never changes a score or contacts a rater.
See Trial QCWhy speech
Speech carries motor, cognitive and psychiatric signs
Speaking uses the brain, breathing, the voice box and the muscles of the mouth together, so one short session can hold all of these signs.
More readings between visits
Short sessions at home between site visits, so a change in grade can show up before the next visit. In a dose-finding study, each dose arm has more readings before the dose decision; readings per arm are seen only by the independent statistician and data monitoring committee.
Nothing to wear
A tap to start on the participant’s own phone. No wearable to ship, charge or return, and no extra site visit.
State of the art, and no black box
Named voice and language features behind every reading. The reference model is calibrated on your study’s screening and baseline ratings, blind to arm and locked before any post‑baseline reading; success criteria are fixed in writing with your statisticians. For your statistician ›
Why Cephalgo
Your scale, your audio, stable when phones change
Readings on the scale your trial already scores, so rater, scale and scoring stay unchanged.
How a reading is made Your audioAudio you holdRe‑analysis of the audio or video a completed or ongoing trial holds, as consented under its protocol, with no new collection or protocol change. From a completed trial, variance components to size your next study.
Re-analysis pilot Phone changesStable readingsRecalibrated from the audio alone, blind to arm, when a phone or its software changes.
Device changesWays to start
Pick a starting scope
Start from recordings you already hold, from baseline in a new study, from rating interviews at each data transfer, or before the screening visit. The fee and timeline are fixed in writing before any data moves.
Existing recordings
Lowest-risk startProspective study
New recordingsTrial QC
Rating interviewsPre-screening
Entry criteriaNew to speech? Added as an exploratory endpoint; your primary endpoint and visit schedule stay as they are ›
Already using a speech vendor? A second reading and a stability audit; your vendor stays in place ›
Running your own speech models? Named features; your own measures recalibrated when phones change ›
News and resources
What’s new at Cephalgo
Our methods are presented at scientific meetings on neurology, CNS trials and digital biomarkers. White papers on Alzheimer’s, Parkinson’s, Huntington’s and ALS are available on request from our research page.
Speech‑based assessment in Alzheimer’s disease and MCI
2026 · Request White paper
Speech‑based assessment in Parkinson’s disease
2026 · Request Poster
Noise‑cancellation variability as a source of longitudinal drift in speech‑based digital endpoints for Alzheimer’s disease trials
CTAD · Boston · November 2026